The CDC has issued its updated 2026 adult immunization schedule, adding refined RSV vaccine eligibility, annual COVID-19 boosters, and clarified pneumococcal options. The changes aim to simplify ...
—Among adults, coverage and preventable burdens were lowest for pneumococcal conjugate vaccine (PCV) 15 and highest for PCV31, with PCV21 preventing notable burdens of both acute respiratory ...
CHICAGO, March 18, 2026 /PRNewswire/ -- Pneumococcal pneumonia is a potentially serious bacterial lung infection that causes approximately 225,000 hospitalizations among adults in the U.S. each year.